Consolidated Planning Corp Takeda Pharmaceutical CO LTD Transaction History
Consolidated Planning Corp
- $550 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
340Shares Held
76.2MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$177 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X012.1MShares$163 Million2.47% of portfolio
-
Morgan Stanley New York, NY5MShares$67.5 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.21MShares$56.9 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.12MShares$42.1 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...